Literature DB >> 27166121

Smoking history, nicotine dependence and opioid use in patients with chronic non-malignant pain.

K Plesner1, H I Jensen2,3, J Højsted4.   

Abstract

BACKGROUND: Previous studies have demonstrated a positive association between smoking and addiction to opioids in patients with chronic non-malignant pain. This could be explained by a susceptibility in some patients to develop addiction. Another explanation could be that nicotine influences both pain and the opioid system. The objective of the study was to investigate whether smoking, former smoking ± nicotine use and nicotine dependence in patients with chronic non-malignant pain were associated with opioid use and addiction to opioids.
METHODS: The study was a cross-sectional study carried out at a multidisciplinary Danish pain centre. All patients aged 18 or more in treatment at the pain centre on the 1st of September 2013 were invited to participate in the study.
RESULTS: A total of 98 patients (65%) participated in the study. The prevalence of current smokers was twice as high as in the general population. The prevalence of patients using opioids was 54% and the prevalence of addiction to opioids was 6%. No significant differences in addiction were found between the different smoking groups, but smokers and former smokers using nicotine tended to use opioids more frequently and at higher doses than never smokers and former smokers not using nicotine.
CONCLUSIONS: The study supports previous evidence that smoking is associated with chronic pain. Our data suggest that information about use of nicotine substitution in chronic non-malignant patients are relevant both in a clinical setting, but also in future studies of the association between smoking habits, pain and opioid use.
© 2016 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27166121     DOI: 10.1111/aas.12741

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

Review 1.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

2.  Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder.

Authors:  R Kathryn McHugh; Amy C Janes; Margaret L Griffin; Nadine Taghian; Shelly F Greenfield; Roger D Weiss
Journal:  Subst Use Misuse       Date:  2020-02-10       Impact factor: 2.164

3.  Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain.

Authors:  Martin D Cheatle; Mary Falcone; Lara Dhingra; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2020-02-14       Impact factor: 4.492

4.  Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use.

Authors:  Sarah D Lichenstein; Yasmin Zakiniaeiz; Sarah W Yip; Kathleen A Garrison
Journal:  Curr Addict Rep       Date:  2019-04-27

5.  Enhancement of Opioid Antinociception by Nicotine.

Authors:  Fernando Barreto de Moura; Sarah Louise Withey; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2019-09-16       Impact factor: 4.030

6.  Treating Nicotine Dependence and Preventing Smoking Relapse in Cancer Patients.

Authors:  Eun Hae Estelle Chang; Andrew Braith; Brian Hitsman; Robert A Schnoll
Journal:  Expert Rev Qual Life Cancer Care       Date:  2016-12-28

7.  Relationship between pain outcomes and smoking history following video-assisted thoracic surgery for lobectomy: a retrospective study.

Authors:  Tak Kyu Oh; Kwhanmien Kim; Sanghoon Jheon; Sang-Hwan Do; Jung-Won Hwang; Jin Hee Kim; Young-Tae Jeon; In-Ae Song
Journal:  J Pain Res       Date:  2018-04-06       Impact factor: 3.133

8.  Nicotine and Opioids: a Call for Co-treatment as the Standard of Care.

Authors:  Chad D Morris; Christine E Garver-Apgar
Journal:  J Behav Health Serv Res       Date:  2020-10       Impact factor: 1.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.